Boston Scientific to Acquire Bolt Medical
Boston Scientific will acquire Bolt Medical, developer of an intravascular lithotripsy (IVL) platform for artery disease.
Boston Scientific will acquire Bolt Medical, developer of an intravascular lithotripsy (IVL) platform for artery disease.
Boston Scientific has received 510(k) clearance from the U.S. FDA for the LUX-Dx Insertable Cardiac Monitor System, a device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation, cryptogenic stroke, and syncope.
Boston Scientific will acquire Bolt Medical, developer of an intravascular lithotripsy (IVL) platform for artery disease.